Pure Financial Advisors »

Fs Global Cr Opportunitie Fda shares owned by Pure Financial Advisors

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Pure Financial Advisors from 13F filings

Historical chart of Pure Financial Advisors investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Pure Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Pure Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $69k 12k 5.93
2023-12-31 $66k 12k 5.67
2023-09-30 $63k 12k 5.42
2023-06-30 $55k 12k 4.75

More positions owned by Pure Financial Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core Msci Eafe (IEFA)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Vanguard Index Fds Real Estate Etf (VNQ)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Spdr Index Shs Fds Glb Nat Resrce (GNR)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
American Centy Etf Tr Intl Smcp Vlu (AVDV)

View all positions for Pure Financial Advisors

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Nomura Holdings
Cambridge Investment Research Advisors
Thomas J. Herzfeld Advisors
Saba Capital Management
Wagner Wealth Management
Penserra Capital Management
Advisor Group Holdings
H D Vest Advisory Services
Rockefeller Capital Management
Royal Bank of Canada
Kestra Advisory Services
Ellis Investment Partners
Prime Capital Investment Advisors
Feltz Wealth PLAN

View all funds holding Fs Global Cr Opportunitie Fda